Index by author

March 01, 2007; Volume 74,Issue 3 suppl 2

Proceedings of a National Dialogue on Biomedical Conflicts of Interest and Innovation Management, September 20, 2006

  1. Cassell, Gail H.

    1. Interactions of the public and private sectors in drug development: Boundaries to protect scientific values while preserving innovation
      Guy M. Chisolm, PhD and Gail H. Cassell, PhD, DSc (hon)
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S45-S48;

  2. Cassell, Panelists Gail H.

    1. Applications in the real world: Case studies in defining boundaries and managing innovation
      Guy M. Chisolm, PhD, Claudia R. Adkison, JD, PhD, Michael J. Meehan, Esq, Panelists Gail H. Cassell, PhD, DSc (hon), Jeffrey P. Kahn, PhD, MPH, Philip A. Pizzo, MD and Thomas P. Stossel, MD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S51-S59;

  3. Chisolm, Guy M.

    1. The mandate of innovation management
      Guy M. Chisolm, PhD and Delos M. Cosgrove, MD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S6-S7;
    2. Applications in the real world: Case studies in defining boundaries and managing innovation
      Guy M. Chisolm, PhD, Claudia R. Adkison, JD, PhD, Michael J. Meehan, Esq, Panelists Gail H. Cassell, PhD, DSc (hon), Jeffrey P. Kahn, PhD, MPH, Philip A. Pizzo, MD and Thomas P. Stossel, MD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S51-S59;
    3. Medical devices and conflict of interest: Unique issues and an industry code to address them
      Guy M. Chisolm, PhD and Paul A. LaViolette, MBA
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S26-S28;
    4. Conflicts, compliance, and enforcement: Government priorities and initiatives
      Guy M. Chisolm, PhD, Jeffrey P. Kahn, PhD, MPH, Bernard A. Schwetz, DVM, PhD and James G. Sheehan
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S68-S69;
    5. Prologue: A case study in biomedical conflicts
      Guy M. Chisolm, PhD and Nina Totenberg
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S8-S9;
    6. Beyond disclosure: The necessity of trust in biomedical research
      Guy M. Chisolm, PhD and Jeffrey P. Kahn, PhD, MPH
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S49-S50;
    7. Interactions of the public and private sectors in drug development: Boundaries to protect scientific values while preserving innovation
      Guy M. Chisolm, PhD and Gail H. Cassell, PhD, DSc (hon)
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S45-S48;
    8. Creating an institutional conflict-of-interest policy at Johns Hopkins: Progress and lessons learned
      Guy M. Chisolm, PhD and Edward D. Miller, MD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S70-S72;
    9. The rapidly changing landscape of biomedical conflicts of interest
      Guy M. Chisolm, PhD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S3-S5;
    10. Guidelines and performance: Creating a culture of ethics
      Guy M. Chisolm, PhD, Susan H. Ehringhaus, JD, Edward D. Miller, MD and Edward Soule, CPA, PhD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S77-S80;
    11. Protecting subjects without hampering research progress: Guidance from the Office for Human Research Protections
      Guy M. Chisolm, PhD and Bernard A. Schwetz, DVM, PhD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S60-S62;
    12. The challenge for NIH ethics policies: Preserving public trust and biomedical progress
      Guy M. Chisolm, PhD and Norka Ruiz Bravo, PhD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S29-S31;
    13. Managing ethical performance in organizations: Insights from the corporate world
      Guy M. Chisolm, PhD and Edward Soule, CPA, PhD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S73-S76;
    14. Overregulation of conflicts hinders medical progress
      Guy M. Chisolm, PhD and Thomas P. Stossel, MD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S14-S15;
    15. Innovation and industry-academia interactions: Where conflicts arise and measures to avoid them
      Guy M. Chisolm, PhD and P. Roy Vagelos, MD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S12-S13;
    16. Fraud, conflict of interest, and other enforcement issues in clinical research
      Guy M. Chisolm, PhD and James G. Sheehan
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S63-S67;
    17. Guiding principles: Where are we headed?
      Guy M. Chisolm, PhD, Nina Totenberg, Darrell G. Kirch, MD, Paul A. LaViolette, MBA and Norka Ruiz Bravo, PhD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S32-S37;
    18. Conflict-of-interest management: Efforts and insights from the Association of American Medical Colleges
      Guy M. Chisolm, PhD and Darrell G. Kirch, MD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S23-S25;
    19. Research, innovation, and safety: Doing the right thing
      Guy M. Chisolm, PhD, Nina Totenberg, Philip A. Pizzo, MD, Thomas P. Stossel, MD and P. Roy Vagelos, MD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S16-S22;
    20. Fostering innovation without compromising integrity
      Guy M. Chisolm, PhD and Philip A. Pizzo, MD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S10-S11;
    21. Building and retaining trust in the biomedical community
      Guy M. Chisolm, PhD and Dick Thornburgh
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S38-S44;

  4. Cosgrove, Delos M.

    1. The mandate of innovation management
      Guy M. Chisolm, PhD and Delos M. Cosgrove, MD
      Cleveland Clinic Journal of Medicine March 2007, 74 (3 suppl 2) S6-S7;
Back to top

In this issue